Development and Validation of Derivative Spectrophotometric Method for Simultaneous Estimation of Domperidone and Rabeprazole Sodium in Bulk and Dosage Forms
Kamana Crossing
Abstract
Kamana Crossing
Abstract
The use of first order derivative spectroscophotometry allowed simultaneous determination of domperidone and rabeprazole sodium, in fixed dose combination products. The absorbance values at 253.2 nm and 266.4 nm of first derivative spectrum was used for the estimation of domperidone and rabeprazole sodium, respectively without mutual interference. This method obeyed beer’s law in the concentration range of 9-45 µg/ml and 6-30 µg/ml for both domperidone and rabeprazole sodium, respectively. The results of analysis have been validated statistically and recovery studies confirmed the accuracy of the proposed method.
OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The use of first order derivative spectroscophotometry allowed simultaneous determination of domperidone and rabeprazole sodium, in fixed dose combination products. The absorbance values at 253.2 nm and 266.4 nm of first derivative spectrum was used for the estimation of domperidone and rabeprazole sodium, respectively without mutual interference. This method obeyed beer’s law in the concentration range of 9-45 µg/ml and 6-30 µg/ml for both domperidone and rabeprazole sodium, respectively. The results of analysis have been validated statistically and recovery studies confirmed the accuracy of the proposed method.
Key concepts: Domperidone, Rabeprazole, Absorbance, Chemistry, Derivative (finance), Chromatography, Sodium, Second derivative